C. Hamilton

发表

Establishing locoregional control of malignant pleural mesothelioma using high‐dose radiotherapy and 18F‐FDG PET/CT scan correlation

A. Scott, S. Lee, M. Feigen, 2011, Journal of medical imaging and radiation oncology.

A novel endoscopic marker for radiological localization and image-guided radiotherapy in esophageal and gastric cancers (with video).

D. L. Joon, R. Vaughan, M. Efthymiou, 2016, Gastrointestinal endoscopy.

A pilot study of EUS-guided fiducial insertion for the multidisciplinary management of gastric cancer

R. Vaughan, M. Efthymiou, J. Sia, 2014, Endoscopy International Open.

A phase III double-blind randomised study of rectal sucralfate suspension in the prevention of acute radiation proctitis.

D. Joseph, M. Poulsen, K. Dear, 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The use of fiducial markers in image‐guided radiotherapy for gastric cancer

R. Vaughan, J. Sia, C. Hamilton, 2013, Journal of medical imaging and radiation oncology.

Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin?

D. Rischin, M. Poulsen, L. Tripcony, 2006, International journal of radiation oncology, biology, physics.

The effect of anaemia on efficacy and normal tissue toxicity following radiotherapy for locally advanced squamous cell carcinoma of the head and neck.

L. Peters, M. Poulsen, J. Denham, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Simultaneous adjuvant radiotherapy and chemotherapy for stage I and II breast cancer.

D. Joseph, S. Ackland, N. Spry, 1999, Australasian radiology.

All delays before radiotherapy risk progression of Merkel cell carcinoma.

J. Denham, C. Wratten, P. O'Brien, 2004, Australasian radiology.

High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study--TROG 96:07.

Danny Rischin, Michael Poulsen, D. Rischin, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-Risk M erkel C ell C arcinoma o f t he S kin T reated W ith Synchronous C arboplatin/Etop oside a nd R adiation: A T rans- Tasman R adiation O ncology G roup S tudy—TROG 9 6:07

D. Rischin, M. Poulsen, L. Tripcony, 2003 .

Analysis of toxicity of Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group study.

D. Rischin, M. Poulsen, L. Tripcony, 2001, International journal of radiation oncology, biology, physics.

A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study

L. Peters, N. Spry, M. Poulsen, 2001 .

Quality assurance audit in an Australasian phase III trial of accelerated radiotherapy for head and neck cancer (TROG 91.01). Trans-Tasman Radiation Oncology Group.

L. Peters, N. Spry, M. Poulsen, 1999, Australasian radiology.

A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study.

L. Peters, N. Spry, M. Poulsen, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Does waiting time affect the outcome of larynx cancer treated by radiotherapy?

V. Gebski, M. Barton, G. Morgan, 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Benchmarking dosimetric quality assessment of prostate intensity-modulated radiotherapy.

P. Bowden, T. Kron, D. L. Joon, 2012, International journal of radiation oncology, biology, physics.